We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+20.14%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$596M
AUM Growth
+$84M
Cap. Flow
-$5.34M
Cap. Flow %
-0.9%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$517M 86.88%
4,887,932
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$6.08B
$38.3M 6.43%
1,921,118
OKUR
3
OnKure Therapeutics
OKUR
$155M
$17.9M 3.01%
240,922
SPRB
4
Spruce Biosciences
SPRB
$182M
$12.9M 2.17%
28,644
VAPO
5
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$9.01M 1.51%
50,579
-26,249
-34% -$5.34M

Similar funds

RiverVest Venture Management's Q3 2021 Portfolio in Review

As of Q3 2021, RiverVest Venture Management held 5 positions worth $596M, up 16% from $512M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's biggest Q3 2021 reduction was Vapotherm, Inc. Common Stock, cutting an estimated $5.34M.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $596M portfolio in Q3 2021.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q3 2021.
  • RiverVest Venture Management's portfolio value rose 16% quarter-over-quarter to $596M.

Based on RiverVest Venture Management's 13F filing for Q3 2021, filed 12 Nov 2021.